CME Group Inc. (CME) Stock Competitors & Peer Comparison

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 92.7B. In comparison, SPGI has a market cap of 125.7B. Regarding current trading prices, CME is priced at $260.47, while SPGI trades at $426.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 21.86, whereas SPGI's P/E ratio is 26.91. In terms of profitability, CME's ROE is +0.15%, compared to SPGI's ROE of +0.15%. Regarding short-term risk, CME is more volatile compared to SPGI. This indicates potentially higher risk in terms of short-term price fluctuations for CME.Check SPGI's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 92.7B. In comparison, ICE has a market cap of 80.1B. Regarding current trading prices, CME is priced at $260.47, while ICE trades at $141.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 21.86, whereas ICE's P/E ratio is 20.61. In terms of profitability, CME's ROE is +0.15%, compared to ICE's ROE of +0.14%. Regarding short-term risk, CME is more volatile compared to ICE. This indicates potentially higher risk in terms of short-term price fluctuations for CME.Check ICE's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 92.7B. In comparison, MCO has a market cap of 78.6B. Regarding current trading prices, CME is priced at $260.47, while MCO trades at $450.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 21.86, whereas MCO's P/E ratio is 32.24. In terms of profitability, CME's ROE is +0.15%, compared to MCO's ROE of +0.67%. Regarding short-term risk, CME is more volatile compared to MCO. This indicates potentially higher risk in terms of short-term price fluctuations for CME.Check MCO's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 92.7B. In comparison, NDAQ has a market cap of 49.5B. Regarding current trading prices, CME is priced at $260.47, while NDAQ trades at $86.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 21.86, whereas NDAQ's P/E ratio is 26.36. In terms of profitability, CME's ROE is +0.15%, compared to NDAQ's ROE of +0.16%. Regarding short-term risk, CME is more volatile compared to NDAQ. This indicates potentially higher risk in terms of short-term price fluctuations for CME.Check NDAQ's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 92.7B. In comparison, MSCI has a market cap of 44.2B. Regarding current trading prices, CME is priced at $260.47, while MSCI trades at $602.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 21.86, whereas MSCI's P/E ratio is 34.71. In terms of profitability, CME's ROE is +0.15%, compared to MSCI's ROE of -0.64%. Regarding short-term risk, CME is more volatile compared to MSCI. This indicates potentially higher risk in terms of short-term price fluctuations for CME.Check MSCI's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 92.7B. In comparison, COIN has a market cap of 41B. Regarding current trading prices, CME is priced at $260.47, while COIN trades at $157.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 21.86, whereas COIN's P/E ratio is 57.38. In terms of profitability, CME's ROE is +0.15%, compared to COIN's ROE of +0.06%. Regarding short-term risk, CME is less volatile compared to COIN. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check COIN's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 92.7B. In comparison, CBOE has a market cap of 30.4B. Regarding current trading prices, CME is priced at $260.47, while CBOE trades at $293.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 21.86, whereas CBOE's P/E ratio is 24.82. In terms of profitability, CME's ROE is +0.15%, compared to CBOE's ROE of +0.25%. Regarding short-term risk, CME is less volatile compared to CBOE. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check CBOE's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 92.7B. In comparison, FDS has a market cap of 9B. Regarding current trading prices, CME is priced at $260.47, while FDS trades at $244.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 21.86, whereas FDS's P/E ratio is 15.84. In terms of profitability, CME's ROE is +0.15%, compared to FDS's ROE of +0.27%. Regarding short-term risk, CME is less volatile compared to FDS. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check FDS's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 92.7B. In comparison, MORN has a market cap of 7B. Regarding current trading prices, CME is priced at $260.47, while MORN trades at $182.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 21.86, whereas MORN's P/E ratio is 18.86. In terms of profitability, CME's ROE is +0.15%, compared to MORN's ROE of +0.30%. Regarding short-term risk, CME is more volatile compared to MORN. This indicates potentially higher risk in terms of short-term price fluctuations for CME.Check MORN's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 92.7B. In comparison, DNB has a market cap of 4.1B. Regarding current trading prices, CME is priced at $260.47, while DNB trades at $9.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 21.86, whereas DNB's P/E ratio is -101.67. In terms of profitability, CME's ROE is +0.15%, compared to DNB's ROE of -0.01%. Regarding short-term risk, CME is more volatile compared to DNB. This indicates potentially higher risk in terms of short-term price fluctuations for CME.Check DNB's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 92.7B. In comparison, VALU has a market cap of 304.1M. Regarding current trading prices, CME is priced at $260.47, while VALU trades at $33.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 21.86, whereas VALU's P/E ratio is 13.85. In terms of profitability, CME's ROE is +0.15%, compared to VALU's ROE of +0.21%. Regarding short-term risk, CME is less volatile compared to VALU. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check VALU's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 92.7B. In comparison, BTOG has a market cap of 2.7M. Regarding current trading prices, CME is priced at $260.47, while BTOG trades at $1.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 21.86, whereas BTOG's P/E ratio is -0.10. In terms of profitability, CME's ROE is +0.15%, compared to BTOG's ROE of -3.17%. Regarding short-term risk, CME is less volatile compared to BTOG. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check BTOG's competition here